drugset / Trial / NCT00002908

Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00002908

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of bryostatin 1 in treating patients who have relapsed non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

Timeline

Start
1996-12
Primary completion
2000-02
Completion
2001-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Vincristine Small molecule
Subject bryostatin 1 Small molecule

Indications